Aditxt, Inc. Deferred Tax Liabilities, Regulatory Assets
Aditxt, Inc. (ADTX) had Deferred Tax Liabilities, Regulatory Assets of $147.16 thousand as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesRegulatoryAssets · last filed 2025-03-31
- 2024-12-31: Deferred Tax Liabilities, Regulatory Assets $147.16K.
- 2023-12-31: Deferred Tax Liabilities, Regulatory Assets $143.70K.
| Period end | Deferred Tax Liabilities, Regulatory Assets |
|---|---|
| 2024-12-31 | $147.16K 10-K · filed 2025-03-31 |
| 2023-12-31 | $143.70K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |